or Try an Advanced Search...

    ETF Components for IBRN - iShares Neuroscience and Healthcare ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    NBIX A 0.63 4.87
    PTCT B -1.81 4.82
    CERE A -0.09 4.75
    SRPT B 2.32 4.65
    ARGX D -1.33 4.58
    AXNX C 0.25 4.54
    ITCI C -2.19 4.51
    BIIB D 1.87 4.42
    XENE C 1.74 4.20
    BHVN D 1.98 3.69
    IART F 0.49 3.66
    ALKS F 0.80 3.61
    ACAD F -0.18 3.26
    SUPN D 1.85 3.18
    AVDL A 2.84 3.10
    CPRX D -2.00 3.01
    EWTX B 1.19 2.32
    DYN D 0.31 2.07
    PRTA F 4.04 2.05
    SAVA B -0.05 1.73
    SRRK C 1.66 1.64
    LBPH B -6.29 1.48
    WVE C 4.42 1.01
    NMRA F 0.33 0.87
    NVRO F 1.26 0.78
    ALEC F 0.94 0.75
    VYGR D 3.28 0.73
    PEPG C -2.00 0.71
    DNTH C 7.46 0.67
    SLDB D -1.27 0.61
    AVXL F 2.39 0.60
    ANNX D 4.72 0.58
    ANRO F -1.25 0.52
    VNDA B 4.27 0.51
    KYTX F 1.46 0.50
    TRDA D -2.95 0.49
    AXGN F -1.53 0.48
    LRMR D 2.04 0.39
    CAPR D 4.39 0.30
    NPCE D -1.87 0.30
    ABOS F 0.29 0.29
    AMLX F 1.50 0.21
    VTGN F 2.04 0.21
    ABEO F 13.02 0.19
    BWAY C -0.69 0.19
    CVRX F 8.73 0.17
    ATHA F 0.00 0.14

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Neuroscience Biotechnology Alzheimer's Disease Biology Medicine Muscular Dystrophy Pain Schizophrenia Dystrophy Epilepsy Life Sciences Cancer Chemical Compounds Depressive Disorder Duchenne Duchenne Muscular Dystrophy Neurodegenerative Diseases Neurophysiology Rare Diseases
    Industries: Biotechnology Medical Devices Drug Manufacturers - Specialty & Generic Diagnostics & Research Drug Manufacturers - Major

    Recent News for iShares Neuroscience and Healthcare ETF & its Holdings

    Date Stock Title
    May 3 LBPH Longboard Pharmaceuticals EPS of -$0.42 beats by $0.07
    May 3 NBIX Neurocrine Biosciences Presented CAHtalyst™ Pediatric Study Baseline Characteristics and CAHtalog™ Registry Data at PES 2024
    May 3 VYGR Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
    May 3 SRPT Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
    May 3 ABEO Abeona Therapeutics prices its $75M offering; shares rise
    May 3 AXGN AxoGen First Quarter 2024 Earnings: Misses Expectations
    May 3 ABEO Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
    May 3 CVRX CVRx, Inc. (NASDAQ:CVRX) Analysts Are Cutting Their Estimates: Here's What You Need To Know
    May 3 AXGN Axogen Inc (AXGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amidst Challenges
    May 3 DYN Dyne Therapeutics GAAP EPS of -$0.81 misses by $0.01
    May 2 ABEO Buying The Dip In Abeona Therapeutics After The Recent Manufacturing-Related CRL
    May 2 DYN Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
    May 2 XENE Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
    May 2 LBPH Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
    May 2 SRPT Sarepta Therapeutics to Benefit as Regulatory Review on DMD Therapy Picks Up, Morgan Stanley Says
    May 2 SRPT Sarepta Elevidys accelerated approval criticized by ICER exec
    May 2 ALKS Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
    May 2 VYGR Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates
    May 2 SRPT Sarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
    May 2 SRPT Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript
    iShares Neuroscience and Healthcare ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. The fund invests in public equity markets of global region. It invests in stocks of companies operating across neurology biopharmaceuticals or neurological devices sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the NYSE FactSet Global Neuro Biopharma and MedTech Index, by using representative sampling technique. iShares Neuroscience and Healthcare ETF is domiciled in the United States.
    Exchange Traded Funds Biopharmaceutical Blackrock Ishares Neuroscience
    Back to the Main IBRN Page...